With CURE TV®, you have access to a variety of informative and uplifting videos. You’ll find interviews with cancer experts, advocates, patients, caregivers, as well as highlights from our celebratory events showcasing interviews with award winners and celebrity speakers.

Minimal Residual Disease is A Vital Marker for Patients with Multiple Myeloma, Says Expert

July 31st 2020

Dr. Parameswaran Hari discusses the importance of understanding a patient’s MRD if they are receiving the maintenance therapy Sarclisa for multiple myeloma.

EDUCATED PATIENT CLL Webinar: Looking at the CLL Landscape

July 30th 2020

Leading experts in the CLL landscape discuss the latest treatment options for patients and answer questions from the CURE audience.

No 'One Great Answer' When it Comes to What Rights Those Affected By Cancer Have When Returning to Work Amid COVID-19

July 29th 2020

There are some job protected options for patients with cancer, survivors and caregivers to consider when it comes to returning to work during the COVID-19 pandemic. But, as one cancer rights attorney notes, there are many challenges to those options.

Gut Microbiome May Play an Important Role in Immunotherapy in the Future, But More Research is Needed

July 28th 2020

The microorganisms inside a patient's gastrointestinal tract may have a role to play in how immunotherapy can treat certain types of cancer.

CURE Community Vlogs: How One Woman Found Her Way Out of Depression Following Metastatic Breast Cancer

July 26th 2020

After being diagnosed with metastatic breast cancer, nurse Stephanie Walker was thrown into a world of isolation and new depths of depression she “never knew even existed”. Here, she details how working with a therapist and communicating with her family and friends helped her find her way out of the darkness.

CURE Community Vlogs: Laughter As Therapy

July 25th 2020

“Laughter is the best medicine” is a principle that CURE Voices contributor Khevin Barnes takes, well, seriously. In this edition of CURE Community Vlogs, Khevin takes a minute to discuss how laughter can help men with breast cancer find a new outlook on their diagnosis.

Advice for Avoiding the Isolation That Comes with Metastatic Breast Cancer

July 24th 2020

While it may be tempting to “go to that dark place” when feeling the isolation that comes with metastatic breast cancer or a pandemic, Stephanie Walker shares her tips for how to emerge and connect with others.

Success and Momentum Involving Biomarkers in Lung Cancer Has Led to More Treatment Options for Patients

July 24th 2020

In an interview with CURE®, Dr. Jorge Gomez discussed how recent developments in the assessment of biomarkers within the small cell lung cancer and non-small cell lung cancer space have led to approvals of new and expanded therapies.

CURE Community Vlogs: Staying Active At Home Through Virtual Yoga

July 18th 2020

CURE® interviews Voices contributor Tamera Anderson-Hanna on the benefits of continuing to perform yoga at home for both patients with cancer experiencing lymphedema, as well as caregivers looking to address their own mental well-being.

Immunotherapy Could Signal a 'Change in the Treatment Paradigm' For Patients with HCC

July 17th 2020

On the importance of finding more potent and well-tolerated therapies in hepatocellular carcinoma, Dr. Bruno Sangro explains: “The wider the spectrum of choices, the better we will be able to treat our patients.”

Expert Highlights 'Exciting' Future Developments in Lung Cancer Treatment

July 16th 2020

Dr. Timothy Burns, of UPMC Hillman Cancer Center, discusses developments in the treatment of lung cancer over the next several years that have exciting potential to impact the field.

Chemotherapy Type and Sequence Can Impact Hair Retention in Breast Cancer

July 16th 2020

Dr. Julia Rani Nangia explains how certain chemotherapy types and sequencing have different impacts on hair retention for patients with breast cancer.

Scalp Cooling: How Does It Work and How Safe Is It?

July 14th 2020

Hair loss is a common side effect in treatment for cancer, but for patients looking to manage it Dr. Julie Rani Nangia breaks down how scalp cooling can slow down hair loss.

CURE Community Vlog: Cancer Diagnoses Can Be a Distant Memory

July 13th 2020

“When time passes, and you look back it seems like a distant memory.”

Out of Several Recent Drug Approvals in NSCLC, Tabrecta Most 'Practice Changing' of All, According to Expert

July 13th 2020

“One FDA approval that we were quite excited about (is Tabrecta). And I've actually already put some patients on it; it's a very good drug,” Dr. Timothy Burns said in a recent interview.

CURE Community Vlog: Having Great Purpose in Pain After Cancer

July 12th 2020

“At 34, I have another chance to live the rest of my life with a consciousness that there's great purpose in the pain.”

CURE Community Vlog: One Patient's Journey With Merkel Cell Carcinoma

July 11th 2020

“You have to speak up. What you don’t say is the most predictive of the care you don’t get.”

Expert Addresses Fear and Uncertainty Patients with Cancer Feel from COVID-19 Disruptions

July 11th 2020

“There's a lot of miscommunication and number one, I would tell them you don't need to face these decisions alone,” Dr. Pat Basu said in an interview addressing patient’s fear in the midst of the COVID-19 pandemic.

'Mixed Bag': Only a Fraction of Recent Drug Approvals in NSCLC Space 'Considered Practice Changing'

July 10th 2020

The recent surge of drug approvals in the non-small cell lung cancer (NSCLC) space by the Food and Drug Administration (FDA) is quite unusual and only a fraction of them are considered practice changing, according to Dr. Timothy Burns.

Tecentriq Approval in NSCLC 'Stops the Brakes' on PD-L1 Expression

July 9th 2020

An expert explains the importance of the fourth approval of the immunotherapy Tecentriq for certain patients with metastatic non-small cell lung cancer who have a high PD-L1 expression.

Turning Clinical Results Into Change for Patients with Prostate Cancer

July 8th 2020

“We don't know what the best treatment paradigm is for a patient whose disease is most clearly manifest on a PSMA scan as opposed to standard imaging,” said Dr. Michael J. Morris. “All that work has yet to be done, and we can only do it once we have the scan available to us as a tool in the United States.”

How COVID-19 Has Created a 'Shadow Curve' in the Treatment of Cancer and Other Diseases

July 8th 2020

The impact of the COVID-19 pandemic on the cancer landscape has lead to enormous challenges for patients and professionals alike, but the impact of the pandemic will be felt on cancer care for years to come.

The Importance of More Thoughtful Treatment Strategies in High-Risk CLL

July 2nd 2020

“If I only have one tool to treat the disease, I will play with that tool in many different ways. But if I have access to four different tools, then I will give up tool (number) one if I don't feel it's working,” explained Dr. Mazyar Shadman of the Seattle Cancer Care Alliance, about his approach to treating high-risk chronic lymphocytic leukemia in an interview with CURE®.

CURE Community Vlogs: Recommendations On What To Do After Receiving a Cancer Diagnosis

July 1st 2020

Lidia, who was diagnosed with stage 4 lung cancer in 2016, offers her advice for others who have received a cancer diagnosis.

Expert Breaks Down the Three Treatment Modalities Currently Being Investigated in CLL

June 30th 2020

“There’s a lot of work to do in CLL,” said Dr. Mazyar Shadman about the treatments currently being investigated in CLL. “We have been very fortunate to be able to provide a lot of options to our patients, but we shouldn't forget that there's a long way to go.”

Expert Advises Patients with CLL on Three Things They Should Be Aware of To Maximize the Benefit of Upfront Treatment

June 29th 2020

In an interview with CURE®, Dr. Mazyar Shadman discussed ways that patients with chronic lymphocytic leukemia can play a role in ensuring that they are able to reap the benefits of treatment.

What Factors Play a Role in Determining Optimal First Line Treatment for Patients With CLL

June 26th 2020

There are three things that should be considered when deciding what is the optimal treatment in the first line setting for patients with chronic lymphocytic leukemia (CLL), according to Dr. Mazyar Shadman.

Approval of Alunbrig Offers Another Option for ALK-Positive NSCLC, But More Research Is Needed

June 23rd 2020

In an interview with CURE®, Dr. Pail Paik of the Memorial Sloan Kettering Cancer Center discusses the FDA approval of Alunbrig for patients with ALK-positive metastatic non-small cell lung cancer.

CURE Community Vlogs: Making the Little Moments Count Through Cancer

June 21st 2020

“I think until you've been put in a position that I'm in, we sometimes tend to take our lives and time that we have for granted.”

CURE Community Vlogs: Turning Lemons into Lemonade After a Cancer Diagnosis

June 20th 2020

“Everything is perspective. It's how you look at it.”